Guía para la presentación de monografías de postgrado: un aporte desde la biblioteca de Facultad de Medicina, Universidad de la República

This document has been prepared with the aim of contributing to the development of the postgraduate studies. It covers aspects of structure and style by international standards, to achieve normalization in the presentation of the works. It is considered that the proper use of information and the correct form in which this one shoud be presented, not only gives sample of the professional and intellectual solidity of the author, but it directly affects the quality of the publication

Kultur Sel Otak Dan Mata Ikan Kerapu (Chromileptes Altivelis) Untuk Replikasi Viral Nervous Necrosis (Vnn) [Cell Line Chromileptes Alttivelis From Enchepalon and Retina for Viral Nervous Necrosis (Vnn) Replication]

The experiment was deal with propagat cell line from encephalon and retina of grouper Chromileptes altivelis.The cell was isolate propagation of method described following by Chen et al.(1982) from carp and crussian carp fin. The cell line from enchepalon and retina of grouper grew very fast and heavy in medium L-1S.The cell line were then used for viral replication giving,isolated virus with high pathogenicity indicated by mortal effect in short time after administration. The preservation of cell line is in 10% glycerol under -80°C for one year. Thawing will be done every 3 months to ensure the viability of the cell

RBX: The new X-band SAR system from INTA

Revista oficial de la Asociación Española de Teledetección[EN] This paper describes the characteristics and the first results of the RBX system, the new airborne Synthetic Aperture Radar developed at Spanish National Institute of Aerospace Technology. The new system supports submetric resolution with interferometric and polarimetric capabilities. The system architecture has been designed taking into account an easy upgrade ability and the quality of the acquired data, including multiple internal calibration loops.[ES] Este artículo describe las características y los primeros resultados del sistema RBX, nuevo radar de apertura sintética aerotransportado que ha sido desarrollado en el Instituto Nacional de Técnica Aeroespacial. El nuevo sistema soporta resoluciones submétricas con capacidades interferométricas y polarimétricas. La arquitectura del sistema se ha diseñado teniendo en cuenta la facilidad de incorporar mejoras y la calidad de los datos adquiridos, incluyendo múltiples lazos de calibración interna.Larrañaga, J. R., De Porras Bernácer, R., Del Castillo, J., Gimeno, N., Aguilar, P., Baquero, A. M., . . . Sánchez, S. (2014). RBX: The new X-band SAR system from INTA. [RBX: El nuevo radar SAR en banda X del INTA] Revista De Teledeteccion, (41), 89-96. doi:10.4995/raet.2014.2285SWORD899641G. Bonin, P. Dreuillet. 2008. The new ONERA airborne SAR system SETHI. EUSAR, Dresden, Germany.Rodriguez, M. G. (2008). Design of a Coherent Generation and Acquisition System at 1,2GHz. 2008 4th Southern Conference on Programmable Logic. doi:10.1109/spl.2008.4547745Gonzalez Bonilla, M. J., Gomez Miguel, B., Cuerda Muñoz, J. M., Larrañaga Sudupe, J. R., Garcia Rodriguez, M., 2009. INTASAR program. Proceedings IGARSSHORN, RALF; NOTTENSTEINER, ANTON; SCHEIBER, ROLF. 2008. F-SAR – DLR's advanced airborne SAR system onboard DO228. Proceedings EUSARMoreira, A., & Yonghong Huang. (1994). Airborne SAR processing of highly squinted data using a chirp scaling approach with integrated motion compensation. IEEE Transactions on Geoscience and Remote Sensing, 32(5), 1029-1040. doi:10.1109/36.31289

New insights into the genetic etiology of Alzheimer's disease and related dementias

Characterization of the genetic landscape of Alzheimer's disease (AD) and related dementias (ADD) provides a unique opportunity for a better understanding of the associated pathophysiological processes. We performed a two-stage genome-wide association study totaling 111,326 clinically diagnosed/'proxy' AD cases and 677,663 controls. We found 75 risk loci, of which 42 were new at the time of analysis. Pathway enrichment analyses confirmed the involvement of amyloid/tau pathways and highlighted microglia implication. Gene prioritization in the new loci identified 31 genes that were suggestive of new genetically associated processes, including the tumor necrosis factor alpha pathway through the linear ubiquitin chain assembly complex. We also built a new genetic risk score associated with the risk of future AD/dementia or progression from mild cognitive impairment to AD/dementia. The improvement in prediction led to a 1.6- to 1.9-fold increase in AD risk from the lowest to the highest decile, in addition to effects of age and the APOE ε4 allele

Multiancestry analysis of the HLA locus in Alzheimer’s and Parkinson’s diseases uncovers a shared adaptive immune response mediated by HLA-DRB1*04 subtypes

Across multiancestry groups, we analyzed Human Leukocyte Antigen (HLA) associations in over 176,000 individuals with Parkinson’s disease (PD) and Alzheimer’s disease (AD) versus controls. We demonstrate that the two diseases share the same protective association at the HLA locus. HLA-specific fine-mapping showed that hierarchical protective effects of HLA-DRB1*04 subtypes best accounted for the association, strongest with HLA-DRB1*04:04 and HLA-DRB1*04:07, and intermediary with HLA-DRB1*04:01 and HLA-DRB1*04:03. The same signal was associated with decreased neurofibrillary tangles in postmortem brains and was associated with reduced tau levels in cerebrospinal fluid and to a lower extent with increased Aβ42. Protective HLA-DRB1*04 subtypes strongly bound the aggregation-prone tau PHF6 sequence, however only when acetylated at a lysine (K311), a common posttranslational modification central to tau aggregation. An HLA-DRB1*04-mediated adaptive immune response decreases PD and AD risks, potentially by acting against tau, offering the possibility of therapeutic avenues

Propuesta de la Sociedad Española de Farmacia Comunitaria (SEFAC) sobre servicios profesionales farmacéuticos en farmacia comunitaria

Con el presente documento SEFAC ofrece un planteamiento sobre los servicios profesionales farmacéuticos (SPF) a implantar y desarrollar por las farmacias comunitarias en los próximos años justificando la misión y el papel del farmacéutico en su prestación, partiendo de la realidad que supone el hecho de que la farmacia comunitaria constituye uno de los mayores recursos asistenciales de atención primaria, que diariamente presta, además de la dispensación, otras actividades sanitarias profesionales centradas en el paciente y en la población que son susceptibles de constituir otros servicios farmacéuticos, y que existen nuevas necesidades relacionadas con el uso de los medicamentos que generan una morbimortalidad evitable en la población. Este planteamiento tiene como objetivo impulsar la prestación de los SPF desde la farmacia comunitaria con el fin de cubrir las necesidades relacionadas con la atención de los pacientes que utilizan medicamentos y con la salud pública. Para lograr este objetivo se definen términos esenciales como servicios profesionales farmacéuticos, catálogo y cartera de servicios farmacéuticos, se indican las características que deben cumplir estos servicios plasmándolas en un decálogo, se propone una clasificación de los tipos de SPF y se enumeran las premisas necesarias para lograr su implantación. Las características de los servicios incluyen sus especificaciones, la capacitación y certificación, calidad, retribución, financiación y difusión, estableciendo el papel de SEFAC en la formación, capacitación, certificación de los profesionales directamente o en colaboración con otras sociedades científicas, y en la certificación y programas de supervisión externa de los SPF de aquellas farmacias que lo requieran

Staging Parkinson's Disease Combining Motor and Nonmotor Symptoms Correlates with Disability and Quality of Life

Altres ajuts: Fundació La Marató De TV3In a degenerative disorder such as Parkinson's disease (PD), it is important to establish clinical stages that allow to know the course of the disease. Our aim was to analyze whether a scale combining Hoehn and Yahr's motor stage (H&Y) and the nonmotor symptoms burden (NMSB) (assessed by the nonmotor symptoms scale (NMSS)) provides information about the disability and the patient's quality of life (QoL) with regard to a defined clinical stage. Cross-sectional study in which 603 PD patients from the COPPADIS cohort were classified according to H&Y (1, stage I; 2, stage II; 3, stage III; 4, stage IV/V) and NMSB (A: NMSS = 0-20; B: NMSS = 21-40; C: NMSS = 41-70; D: NMSS ≥ 71) in 16 stages (HY.NMSB, from 1A to 4D). QoL was assessed with the PDQ-39SI, PQ-10, and EUROHIS-QOL8 and disability with the Schwab&England ADL (Activities of Daily Living) scale. A worse QoL and greater disability were observed at a higher stage of H&Y and NMSB (p < 0.0001). Combining both (HY.NMSB), patients in stages 1C and 1D and 2C and 2D had significantly worse QoL and/or less autonomy for ADL than those in stages 2A and 2B and 3A and 3B, respectively (p < 0.005; e.g., PDQ-39SI in 1D [ n = 15] vs 2A [ n = 101]: 28.6 ± 17.1 vs 7.9 ± 5.8; p < 0.0001). The HY.NMSB scale is simple and reflects the degree of patient involvement more accurately than the H&Y. Patients with a lower H&Y stage may be more affected if they have a greater NMS burden